Abstract:ObjectiveTo investigate the serological markers associated with posthepatectomy recurrence in patients with hepatocellular carcinoma, and to establish a prognostic model to evaluate whether palliative hepatectomy is suitable for such patients. MethodsA total of 111 patients with hepatocellular carcinoma who underwent hepatectomy in the Affiliated Cancer Hospital of Zhengzhou University from February 2009 to July 2013 and received follow-up were enrolled. Basic clinical data were collected and the patients were divided into recurrence group and non-recurrence group according to whether recurrence was observed during follow-up. The t-test was used for comparison of normally distributed continuous data between two groups and the Wilcoxon rank sum test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. Survival curves were plotted using the Kaplan-Meier method, and survival differences were analyzed using the log-rank test. A Cox regression analysis was used to perform univariate and multivariate analyses, and the area under the ROC curve (AUC) was used to evaluate prediction efficiency. ResultsThe Kaplan-Meier survival curves showed that the patients with low alpha-fetoprotein (AFP), alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), and fibrinogen and high CXCL13 had a longer median time to recurrence (P＜0.05). AFP (hazard ratio ［HR］［95%CI］=1.69(1.03~2.79), P=0.039), GGT (HR［95%CI］=1.89(1.14~3.14), P=0.014), and CXCL13 (HR［95%CI］=0.54(0.33~0.89), P=0.015) were independent factors associated with posthepatectomy recurrence. The prognostic index PI=0.526×AFP+0.637×GGT-0.616×CXCL13 established based on these factors had an AUC of 0.87, a sensitivity of 93.75%, and a specificity of 63.64% in predicting recurrence within 0-3 months after palliative hepatectomy, with a significant reduction in prediction efficiency for recurrence within 0-6 months (AUC=0.68) or a longer period of time. The recurrence prediction efficiency of this model for palliative hepatectomy was significantly higher than that for radical resection. ConclusionThe prognostic model established based on CXCL13, AFP, and GGT can be used to evaluate the risk of early recurrence after palliative hepatectomy and thus helps clinicians to make diagnosis and treatment decisions based on patients’ benefits.

Galectin-4 expression in early recurrence and/or metastasis after surgery of huge hepatocellular carcinoma, and study of mathematical prediction model

Expression Of Galectin-9 Mrna In Hepatocellular Carcinoma

Correlation of nm23 and E-cadherin protein expression with recurrence and metastasis after liver transplantation for hepatocellular carcinoma

A Mathematical Model to Predict Short-Term Recurrence and Metastasis of Primary Hepatocellular Carcinoma Larger than 10cm in Diameter.

Galectin-4 Serves As a Prognostic Biomarker for the Early Recurrence / Metastasis of Hepatocellular Carcinoma.

Expressions of Galectin-3 and Galectin-9 in Hepatocellular Carcinoma Patients and Their Relationship with Prognosis

Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection

A Model Combining TNM Stage and Tumor Size Shows Utility in Predicting Recurrence among Patients with Hepatocellular Carcinoma after Resection.

Development of Preoperative and Postoperative Machine Learning Models to Predict the Recurrence of Huge Hepatocellular Carcinoma Following Surgical Resection.

Construction and analysis of a predictive model for posthepatectomy recurrence in patients with hepatocellular carci-noma based on preoperative CXCL13 measurement

Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma

Prediction of metastasis and recurrence of hepatocellular carcinoma after surgical resection

Prognostic Factors of Survival in Patients with Huge Hepatocellular Carcinoma after Hepatectomy

The Establishment of the Mathematical Prediction Model Linked to Cinically Relevant Factors and CXCR7 after Curative Hepatic Resection

Overexpression of Galectin‐1 is Associated with Poor Prognosis in Human Hepatocellular Carcinoma Following Resection

An initial design and application of CT imaging prediction model on early interhepatic recurrence and metastasis of hepatocellular carcinoma

Clinical and Morpho-Molecular Classifiers for Prediction of Hepatocellular Carcinoma Prognosis and Recurrence after Surgical Resection.

A Scoring System for Prediction of Early Recurrence after Liver Resection for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection

Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma

Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases